Taiping Shi

1.4k total citations
46 papers, 925 citations indexed

About

Taiping Shi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Taiping Shi has authored 46 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Genetics. Recurrent topics in Taiping Shi's work include Ubiquitin and proteasome pathways (9 papers), Cancer-related Molecular Pathways (7 papers) and Cell death mechanisms and regulation (5 papers). Taiping Shi is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Cancer-related Molecular Pathways (7 papers) and Cell death mechanisms and regulation (5 papers). Taiping Shi collaborates with scholars based in China, United States and United Kingdom. Taiping Shi's co-authors include Dalong Ma, Weiwei Deng, Jinhai Guo, Pingzhang Wang, Quansheng Song, Lu Yang, Chuanfei Yu, Pengfei He, Lan Wang and Chenying Zhang and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Biochemical and Biophysical Research Communications.

In The Last Decade

Taiping Shi

46 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taiping Shi China 20 577 206 153 153 146 46 925
Liu-Ya Tang United States 13 758 1.3× 138 0.7× 125 0.8× 199 1.3× 148 1.0× 16 1.2k
Marian L. Burr United Kingdom 11 541 0.9× 125 0.6× 110 0.7× 116 0.8× 163 1.1× 13 860
Padmaja Gade United States 15 414 0.7× 213 1.0× 119 0.8× 115 0.8× 232 1.6× 21 841
Inmaculada Hernández‐Muñoz Spain 18 808 1.4× 183 0.9× 143 0.9× 282 1.8× 109 0.7× 30 1.1k
Gary Kasof United States 10 732 1.3× 185 0.9× 145 0.9× 158 1.0× 229 1.6× 10 937
Anne Vézina Canada 17 504 0.9× 100 0.5× 130 0.8× 219 1.4× 98 0.7× 18 927
Mary C. Stevenson United States 12 395 0.7× 135 0.7× 97 0.6× 289 1.9× 105 0.7× 14 869
Mathieu Lajoie Canada 14 399 0.7× 138 0.7× 139 0.9× 158 1.0× 96 0.7× 24 712
Kee‐Beom Kim South Korea 22 908 1.6× 164 0.8× 170 1.1× 287 1.9× 85 0.6× 39 1.2k
Juinn-Lin Liu United States 11 763 1.3× 136 0.7× 227 1.5× 248 1.6× 100 0.7× 11 1.1k

Countries citing papers authored by Taiping Shi

Since Specialization
Citations

This map shows the geographic impact of Taiping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taiping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taiping Shi more than expected).

Fields of papers citing papers by Taiping Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taiping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taiping Shi. The network helps show where Taiping Shi may publish in the future.

Co-authorship network of co-authors of Taiping Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Taiping Shi. A scholar is included among the top collaborators of Taiping Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taiping Shi. Taiping Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Chuanfei, Ning Zhao, Jinhai Deng, et al.. (2018). In vitro study of FUZ as a novel potential therapeutic target in non-small-cell lung cancer. Life Sciences. 197. 91–100. 6 indexed citations
2.
Deng, Weiwei, Lan Wang, Ying Xiong, et al.. (2015). The novel secretory protein CGREF1 inhibits the activation of AP-1 transcriptional activity and cell proliferation. The International Journal of Biochemistry & Cell Biology. 65. 32–39. 20 indexed citations
3.
Zheng, Hongwei, Guobin Fu, Jingsong Yuan, et al.. (2012). Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D. Lung Cancer. 79(2). 104–110. 17 indexed citations
4.
Huang, Jing, Li Zhang, Wei Liu, et al.. (2012). CCDC134 interacts with hADA2a and functions as a regulator of hADA2a in acetyltransferase activity, DNA damage-induced apoptosis and cell cycle arrest. Histochemistry and Cell Biology. 138(1). 41–55. 21 indexed citations
5.
Shi, Taiping, Ying Xiong, Weiwei Deng, et al.. (2011). Human HS1BP3 induces cell apoptosis and activates AP-1. BMB Reports. 44(6). 381–386. 8 indexed citations
6.
Jin, Peng, Xiaojuan Lu, Jianqiu Sheng, et al.. (2010). Estrogen Stimulates the Expression of Mismatch Repair Gene hMLH1 in Colonic Epithelial Cells. Cancer Prevention Research. 3(8). 910–916. 24 indexed citations
7.
Peng, Zhi, Taiping Shi, & Dalong Ma. (2010). RNF122: A novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand. BMC Cell Biology. 11(1). 41–41. 14 indexed citations
8.
Zhang, Heyu, Xi Ma, Taiping Shi, et al.. (2009). NSA2, a novel nucleolus protein regulates cell proliferation and cell cycle. Biochemical and Biophysical Research Communications. 391(1). 651–658. 26 indexed citations
9.
Wang, Pingzhang, Peng Yu, Peng Gao, Taiping Shi, & Dalong Ma. (2009). Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site. BMC Genomics. 10(1). 518–518. 12 indexed citations
10.
Fu, Dongxu, Linjie Tian, Zhi Peng, et al.. (2009). Overexpression of CHMP6 Induces Cellular Oncosis and Apoptosis in HeLa Cells. Bioscience Biotechnology and Biochemistry. 73(3). 494–501. 10 indexed citations
11.
Yu, Chuanfei, Lan Wang, Lu Yang, et al.. (2008). TMEM74, a lysosome and autophagosome protein, regulates autophagy. Biochemical and Biophysical Research Communications. 369(2). 622–629. 45 indexed citations
12.
Ma, Teng, Taiping Shi, Jing Huang, et al.. (2008). DCUN1D3, a novel UVC‐responsive gene that is involved in cell cycle progression and cell growth. Cancer Science. 99(11). 2128–2135. 22 indexed citations
13.
Yuan, Jingsong, Jinfang Ma, Hongwei Zheng, et al.. (2008). Overexpression of OLC1, Cigarette Smoke, and Human Lung Tumorigenesis. JNCI Journal of the National Cancer Institute. 100(22). 1592–1605. 19 indexed citations
14.
Wang, Lan, Weiwei Deng, Taiping Shi, & Dalong Ma. (2008). URP2SF, a FERM and PH domain containing protein, regulates NF-κB and apoptosis. Biochemical and Biophysical Research Communications. 368(4). 899–906. 6 indexed citations
15.
Luo, Ye, Yu Hao, Taiping Shi, Wei‐Wei Deng, & Na Li. (2008). Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif. Acta Pharmacologica Sinica. 29(5). 628–633. 21 indexed citations
16.
Wang, Lan, Chuanfei Yu, Lu Yang, et al.. (2007). TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis. APOPTOSIS. 12(8). 1489–1502. 73 indexed citations
17.
Huang, Jintao, Taiping Shi, Xi Ma, et al.. (2007). CCDC134, a novel secretory protein, inhibits activation of ERK and JNK, but not p38 MAPK. Cellular and Molecular Life Sciences. 65(2). 338–349. 31 indexed citations
18.
Tian, Linjie, Pingzhang Wang, Jinhai Guo, et al.. (2007). Screening for novel human genes associated with CRE pathway activation with cell microarray. Genomics. 90(1). 28–34. 14 indexed citations
20.
Wang, Pingzhang, Taiping Shi, & Dalong Ma. (2006). Cloning of a novel human caspase-9 splice variant containing only the CARD domain. Life Sciences. 79(10). 934–940. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026